Global Cell And Gene Therapy Clinical Trial Services Market Analysis for 2026–2030 with Strategic Forecast Insights for Businesses
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Cell And Gene Therapy Clinical Trial Services Market Projected To Become By 2030 Based On Its 2026 Valuation?
The cell and gene therapy clinical trial services market has experienced significant expansion in recent years. It is anticipated to grow from $4.18 billion in 2025 to $4.62 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.3%. The growth observed in the historic period was driven by an escalating number of cell and gene therapy clinical trials, an increase in outsourcing to specialized CROs, the evolving complexity of trial designs, the broadening scope of rare disease research, and heightened regulatory oversight of advanced therapies.
The cell and gene therapy clinical trial services market is projected to experience robust expansion over the coming years. It is anticipated to reach $6.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.7%. This projected increase throughout the forecast period stems from factors such as a heightened demand for late-stage clinical trial services, greater embrace of digital trial technologies, broader global patient recruitment efforts, an intensified focus on incorporating real-world evidence, and increased funding in precision clinical research. Key developments expected during this timeframe involve a rise in decentralized clinical trial models, wider deployment of digital patient recruitment platforms, enhanced integration of sophisticated data management systems, the broadening of global trial site networks, and a reinforced emphasis on regulatory adherence and trial precision.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp
What Primary Drivers Are Shaping The Development Of The Cell And Gene Therapy Clinical Trial Services Market?
The increasing occurrence of genetic conditions is projected to boost the expansion of the cell and gene therapy clinical trial services market in the future. These are health problems resulting from alterations in an individual’s DNA or genetic makeup. Several factors contribute to the growing frequency of genetic diseases, such as greater access to genetic testing, the emergence of genetic mutations, and the common practice of consanguineous marriage. Cell and gene therapy clinical trial services are crucial in tackling the rising prevalence of genetic diseases by fostering the creation of new treatments, customizing therapies for patients, expediting the transition of research into clinical application, and broadening the therapeutic choices for those with genetic disorders. For example, in 2023, data from the National Health Service, a UK government body, indicated that in England, sickle cell disorder (SCD) stands as the most common genetic condition, affecting approximately 17,000 individuals (NHSE, 2023). Consequently, the growing incidence of genetic disease acts as a key driver for the growth of the cell and gene therapy clinical trial services market.
What Segment Groups Are Identified Within The Cell And Gene Therapy Clinical Trial Services Market?
The cell and gene therapy clinical trial services market covered in this report is segmented –
1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services
2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy
3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications
4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Clinical Trial Design And Planning: Protocol Development, Trial Feasibility Studies, Trial Design Consultation, Patient Recruitment And Enrollment Strategy, Risk-Based Monitoring Plans
2) By Supply And Logistic Services: Clinical Trial Supply Chain Management, Cold Chain Logistics, Packaging And Labeling Services, Transportation And Distribution Of Biological Samples, Customs And Import/Export Services
3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting, Regulatory Submission And Documentation, Compliance With GMP (Good Manufacturing Practices), Regulatory Pathway Consultation, Clinical Trial Applications (CTAs)
4) By Data Management And Biostatistics: Clinical Data Management (CDM), Statistical Analysis And Reporting, Clinical Data Monitoring, Data Integration And Validation, Electronic Data Capture (EDC) Solutions
5) By Site Management And Monitoring: Site Selection And Initiation, Clinical Monitoring And Site Visits, Patient Recruitment And Retention, Site Training And Support, Site Performance Monitoring
6) By Other Services: Patient Advocacy And Engagement, Real-World Evidence (RWE) Studies, Post-Trial Services, Medical Writing And Documentation, Clinical Trial Auditing And Inspection
What Major Market Trends Are Driving Changes In The Cell And Gene Therapy Clinical Trial Services Market?
Major companies within the cell and gene therapy clinical trial services market are concentrating their efforts on deploying advanced technology, including customer relationship management systems, to enhance efficiency and gain a competitive edge. The customer relationship management system, as employed by cell and gene therapy clinical trial services, streamlines and synchronizes interactions with trial participants, healthcare providers, and other stakeholders across the entire clinical trial process. For instance, in April 2023, AmerisourceBergen Corporation, a healthcare company based in the US, unveiled the Cell and Gene Therapy (CGT) Integration Hub, a platform intended to improve connectivity and rationalize processes throughout the cell and gene therapy treatment pathway. This platform, which is underpinned by AmerisourceBergen’s customer relationship management (CRM) system, endeavors to simplify the path-to-care process, partly by providing physicians and patient services teams with greater visibility across the therapy development and delivery journey. The CGT Integration Hub, featuring elements like expedited benefits investigation, real-time status tracking, and proactive alerts, is designed to simplify care coordination, minimize impediments, and enhance the overall patient and provider experience when delivering cell and gene therapies.
Which Companies Hold Significant Positions In The Cell And Gene Therapy Clinical Trial Services Market?
Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.
Read the full cell and gene therapy clinical trial services market report here:
How Does The Cell And Gene Therapy Clinical Trial Services Market Perform Across Major Global Regions?
North America was the largest region in the cell and gene therapy clinical trial services market in 2025. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Cell And Gene Therapy Clinical Trial Services Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15535&type=smp
Browse Through More Reports Similar to the Global Cell And Gene Therapy Clinical Trial Services Market 2026, By The Business Research Company
Cell And Gene Therapy Supply Chain Or Logistics Global Market Report
Cell And Gene Therapy Clinical Trial Services Global Market Report
Cell And Gene Therapy Contract Development And Manufacturing Organization Cdmo Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
